REGN-COV2

casirivimab; imdevimab · Regeneron

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN-COV2, covering 2021-02-01 to 2021-02-01. Get the full timeline:

Most recent: EMA starts rolling review of REGN-COV2 antibody combination (casirivimab / imdevimab)